If you are involved in topical formulations (innovator and generics), you’ll benefit from this 40-minute webinar plus Q&A. That includes but is not limited to those in R&D, regulatory affairs, quality assurance, quality control, and academics.
During this comprehensive webinar, we’ll provide insights into:
- The main objectives, principles and methodologies of an IVPT study
- The role of IVPT method as a surrogate alternative
- Membrane, media and permeation enhancers for IVPT
- Current challenges and future perspectives topical product bioequivalence
- Case studies providing practical, real-world examples of IVPT
Your expert presenter will be Dr. Theo Kapanadze, co-founder and chief scientific officer of Diteba Inc., a leader in dermal and transdermal research services. Diteba has been pivotal in advancing drug development and securing numerous innovator and generic drug approvals. Dr. Kapanadze has 20-plus years of research experience in analytical R&D chemistry and the pharmaceutical, biopharmaceutical, and nutraceutical industries. He earned his Ph.D. and D.Sc. in the chemistry of biological active compounds.
It will be time well spent to receive guidance you can immediately apply in your own lab, now and in the future. Following the webinar, you’ll have a great opportunity to ask questions specific to your own applications, which will be answered via email.
